Weekly Recap | JPMorgan Chase -1.84%, lagging the S&P 500

The Week

JPMorgan Chase (JPM) fell 1.84% this week to close at $349.67, while the S&P 500 slipped 0.08%, leaving the stock about 1.76 percentage points behind the benchmark. Trading was choppy. After opening Monday at $354.23, the shares hit a weekly low of $343.072 on Tuesday, bounced to $352.49, reached a high of $355.60 on Wednesday, then faded to $349.31 on Thursday and $349.67 on Friday. Weekly amplitude was 3.54%. The stock sits below its 20-day average at $354.471 and near its 60-day average at $349.874. Over the last 60 sessions, the range runs from $325.01 to $366.5.

Key Events

Company-specific news was dominated by operational changes and capital-markets activity. Julie Harris, head of operations for asset & wealth management, is set to retire in 2027. On the financing side, JPMorgan and Banco Santander are reported to lead a £1.1 billion loan backing Drax’s solar acquisition. JPMorgan also became depositary bank for Kazia Therapeutics’ ADR programme and is involved in the underwriting chain for Nscale’s US IPO. A series of 424B2 filings showed continued issuance of structured products, consistent with the bank’s active role in frequent debt issuance.

On the macro side, JPMorgan joined Bank of America and Citi in repricing its prime rate to 7% after the Fed hike, and the shares slipped intraday as that repricing was flagged. Separately, JPMorgan researchers said they can no longer predict the next move in the Iran war and abandoned their oil price forecast; on crypto regulation, they warned that agency rules lack durability after the CLARITY Act failed. These items largely reflect research views rather than changes to the bank’s own fundamentals.

Analyst Ratings

Of 25 institutions covering the stock, 9 rate it buy, 4 rate it overweight, 10 rate it hold, 1 rates it underweight, 0 rate it sell, and 1 has no opinion. That adds up to 13 buy or overweight ratings. The consensus rating is buy, with a consensus target of $375.38, roughly 7.35% above the latest close of $349.67. Targets range from $305 to $436, pointing to wide disagreement about rate trajectories and capital-markets earnings. Among 59 names in the diversified banks industry, the stock ranks second.

The Week Ahead

On the data front, the Richmond Fed composite index arrives on 22 September, followed by EIA crude and Cushing inventory numbers on 23 September. Jobless claims, the current account balance, new home sales and EIA natural gas storage are all due on 24 September. JPMorgan’s own earnings are still a few weeks out: its Q3 FY2026 report is scheduled for 13 October pre-market, with consensus estimates at $5.8165 EPS and $50.7 billion revenue. Macro data and geopolitical sentiment may keep driving bank-sector risk appetite, while company-specific catalysts remain limited until then.

In Short

JPMorgan pulled back roughly in line with the tape, lagging the S&P 500 by about 1.76 percentage points and holding near its 60-day average. The broker picture stays constructive: 13 of 25 institutions rate the stock buy or overweight, and the consensus target sits about 7.35% above spot, though targets from $305 to $436 signal real dispersion. On the latest trading day, large-lot money showed net inflow while medium and small tickets were net sellers, leaving flows mixed; valuation stands at 14.61x P/E and 2.63x P/B. The next real test is October earnings, where net interest income, capital-markets performance, and any oil-price or risk-sentiment spillover from the Iran conflict will matter most.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.